Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma

The efficacy of sorafenib in combination with transarterial chemoembolization (TACE) or multiple-line therapies in patients with advanced hepatocellular carcinoma (HCC) remains unclear. This study aimed to investigate the overall survival (OS) of patients with advanced HCC in response to different c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicine (Baltimore)
Asıl Yazarlar: Hsiao, Pojen, Hsieh, Kun-Chou, Chen, Yaw-Sen, Hsu, Chia-Chang, Lo, Gin-Ho, Li, Yu-Chan, Hsieh, Pei-Min, Lin, Hung-Yu, Wu, Tsung-Chin, Yeh, Jen-Hao, Lin, Chih-Wen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer Health 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636964/
https://ncbi.nlm.nih.gov/pubmed/31232945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016074
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller